BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21615384)

  • 21. Circulating microenvironment of CLL: are nurse-like cells related to tumor-associated macrophages?
    Filip AA; Ciseł B; Koczkodaj D; Wąsik-Szczepanek E; Piersiak T; Dmoszyńska A
    Blood Cells Mol Dis; 2013 Apr; 50(4):263-70. PubMed ID: 23313631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
    Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
    Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different expression of CD180, CD284 and CD14 receptors on the CD19+ subpopulation of normal and B-CLL lymphocytes.
    Antosz H; Sajewicz J; Marzec-Kotarska B; Kocki J; Dmoszyńska A
    Folia Histochem Cytobiol; 2009; 47(4):593-8. PubMed ID: 20430725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line.
    Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A
    Br J Haematol; 2005 Sep; 130(6):878-89. PubMed ID: 16156858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells.
    Ghamlouch H; Darwiche W; Hodroge A; Ouled-Haddou H; Dupont S; Singh AR; Guignant C; Trudel S; Royer B; Gubler B; Marolleau JP
    Oncotarget; 2015 Jul; 6(21):18484-503. PubMed ID: 26050196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nurse like cells: chronic lymphocytic leukemia associated macrophages.
    Boissard F; Fournié JJ; Laurent C; Poupot M; Ysebaert L
    Leuk Lymphoma; 2015 May; 56(5):1570-2. PubMed ID: 25586606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient depletion of chronic lymphocytic leukemia B cells using serial rounds of immunomagnetic depletion.
    Weinkove R; Brooks CR; Carter JM; Hermans IF; Ronchese F
    J Immunol Methods; 2013 Oct; 396(1-2):152-6. PubMed ID: 23911312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1.
    Gilling CE; Mittal AK; Chaturvedi NK; Iqbal J; Aoun P; Bierman PJ; Bociek RG; Weisenburger DD; Joshi SS
    Br J Haematol; 2012 Jul; 158(2):216-231. PubMed ID: 22571278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-malignant B cells and chronic lymphocytic leukemia cells induce a pro-survival phenotype in CD14+ cells from peripheral blood.
    Bhattacharya N; Diener S; Idler IS; Barth TF; Rauen J; Habermann A; Zenz T; Möller P; Döhner H; Stilgenbauer S; Mertens D
    Leukemia; 2011 Apr; 25(4):722-6. PubMed ID: 21242995
    [No Abstract]   [Full Text] [Related]  

  • 30. Genomic and phenotypic characterization of nurse-like cells that promote drug resistance in chronic lymphocytic leukemia.
    Ysebaert L; Fournié JJ
    Leuk Lymphoma; 2011 Jul; 52(7):1404-6. PubMed ID: 21699388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunocytochemical investigation of normal and chronic lymphocytic leukaemia lymphocytes reveals unexpectedly frequent reactivity with some myelomonocytic associated antibodies.
    Woessner S; Florensa L; Besses C; Vilà RM; Gallés C; Palou L; Sabrafen JS
    Leuk Res; 1992; 16(5):505-10. PubMed ID: 1378160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revealing some oncofetal antigens in peripheral blood mononuclear cells of donors and patients with B-chronic lymphocytic leukemia.
    Penezina O; Komissarenko S; Tishenco L; Pavlenco A; Moroz S; Bulgakov A; Fomovskaia G
    Leuk Res; 1998 Nov; 22(11):1009-13. PubMed ID: 9783803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reprogramming Nurse-like Cells with Interferon γ to Interrupt Chronic Lymphocytic Leukemia Cell Survival.
    Gautam S; Fatehchand K; Elavazhagan S; Reader BF; Ren L; Mo X; Byrd JC; Tridandapani S; Butchar JP
    J Biol Chem; 2016 Jul; 291(27):14356-14362. PubMed ID: 27226587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a cell-line model to mimic the pro-survival effect of nurse-like cells in chronic lymphocytic leukemia.
    Mohammad IS; Lin K; Oates M; Khan UT; Burger J; Pettitt AR; Zhuang J
    Leuk Lymphoma; 2021 Jan; 62(1):45-57. PubMed ID: 32856983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD14
    Liu J; Zhou Y; Huang Q; Qiu L
    Oncol Lett; 2015 Mar; 9(3):1167-1172. PubMed ID: 25663875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of Nurse-like Cell Differentiation as a Therapeutic Strategy for Chronic Lymphocytic Leukemia.
    Merchand-Reyes G; Santhanam R; Robledo-Avila FH; Weigel C; Ruiz-Rosado JD; Mo X; Partida-Sánchez S; Woyach JA; Oakes CC; Tridandapani S; Butchar JP
    J Immunol; 2022 Sep; 209(6):1212-1223. PubMed ID: 35995507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrantly expressed Wnt5a in nurse-like cells drives resistance to Venetoclax in chronic lymphocytic leukemia.
    Guo Y; Pei H; Lu B; Zhang D; Zhao Y; Wu F; Sun H; Huang J; Li P; Yi C; Zhu C; Pan Y; Wu S; Chen C; Xu X; Chen Y
    Cell Death Discov; 2022 Feb; 8(1):82. PubMed ID: 35210425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vitro Assay to Study CLL and Monocyte Interactions.
    Bertilaccio MTS; Zhang R; Banerjee P; Gandhi V
    Methods Mol Biol; 2019; 1881():113-119. PubMed ID: 30350201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of an increased frequency of CD14+ HLA-DR lo/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL).
    Gustafson MP; Abraham RS; Lin Y; Wu W; Gastineau DA; Zent CS; Dietz AB
    Br J Haematol; 2012 Mar; 156(5):674-6. PubMed ID: 22050346
    [No Abstract]   [Full Text] [Related]  

  • 40. Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples.
    Edwards V DK; Sweeney DT; Ho H; Eide CA; Rofelty A; Agarwal A; Liu SQ; Danilov AV; Lee P; Chantry D; McWeeney SK; Druker BJ; Tyner JW; Spurgeon SE; Loriaux MM
    Oncotarget; 2018 May; 9(37):24576-24589. PubMed ID: 29872489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.